Skip to main content
. 2022 Jul 1;12:939021. doi: 10.3389/fonc.2022.939021

Figure 12.

Figure 12

There was no difference in overall survival between the various risk groups. (A). The mRNAsi was significantly different between normal and tumor tissues (B). Significant differences in mRNAsi between clinicopathological factors (C–F).